EVH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EVH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
A Goodwill is an intangible asset that arises as a result of the acquisition of one company by another for a premium value. The value of a company's brand name, solid customer base, good customer relations, good employee relations and any patents or proprietary technology represent goodwill. Evolent Health's goodwill for the quarter that ended in Dec. 2024 was $1,137 Mil.
The historical data trend for Evolent Health's Goodwill can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Goodwill | Get a 7-Day Free Trial |
![]() |
![]() |
349.03 | 426.30 | 722.77 | 1,116.54 | 1,137.32 |
Evolent Health Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Goodwill | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
1,116.54 | 1,116.54 | 1,116.54 | 1,137.34 | 1,137.32 |
A Goodwill is an intangible asset that arises as a result of the acquisition of one company by another for a premium value. The value of a company's brand name, solid customer base, good customer relations, good employee relations and any patents or proprietary technology represent goodwill. Goodwill is considered an intangible asset because it is not a physical asset like buildings or equipment. The goodwill account can be found in the assets portion of a company's balance sheet.
Evolent Health (NYSE:EVH) Goodwill Explanation
Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.
It is calculated by dividing goodwill by total assets.
Evolent Health's Goodwill-to-Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as
Goodwill-to-Asset (A: Dec. 2024 ) | = | Goodwill | / | Total Assets |
= | 1137.32 | / | 2544.411 | |
= | 0.45 |
Evolent Health's Goodwill-to-Asset Ratio for the quarter that ended in Dec. 2024 is calculated as
Goodwill-to-Asset (Q: Dec. 2024 ) | = | Goodwill | / | Total Assets |
= | 1137.32 | / | 2544.411 | |
= | 0.45 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.
Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.
Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.
Thank you for viewing the detailed overview of Evolent Health's Goodwill provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard M Jelinek | director | 40 W 47TH STREET, FLOOR 33, NEW YORK NY 10035 |
Kim Keck | director | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Peter J Grua | director | C/O HLM VENTURE PARTNERS, 800 SOUTH STREET, SUITE 620, WALTHAM MA 02453 |
Daniel Joseph Mccarthy | officer: PRESIDENT | 800 N GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Craig A. Barbarosh | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Seth Blackley | officer: President | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Diane Holder | director | 800 GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
John Paul Johnson | officer: Chief Financial Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Emily Ann Rafferty | officer: Chief Operating Officer | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Jonathan Weinberg | officer: General Counsel | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Toyin Ajayi | director | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Cheryl Scott | director | 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Mary Bridget Duffy | director | C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126 |
Frank J Williams | director, officer: Chief Executive Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
Steve Tutewohl | officer: Chief Operating Officer | 800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203 |
From GuruFocus
By PRNewswire • 12-18-2024
By GuruFocus News • 11-20-2024
By PRNewswire • 11-07-2024
By GuruFocus News • 03-06-2025
By PRNewswire • 02-04-2025
By GuruFocus News • 02-21-2025
By GuruFocus News • 02-22-2025
By GuruFocus News • 11-12-2024
By GuruFocus News • 11-26-2024
By GuruFocus News • 11-08-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.